Skip to main content
Caplight Logo









Grouport

Grouport

Private
New York City, New YorkHealthcare & Life Scienceshttps://grouporttherapy.com

Last Round

Seed

Sep 9, 2021

Total Funding Raised

$1.5M

Company Overview

Grouport operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in September 2021.

Grouport is a healthcare company that provides online group therapy services intended to enhance overall well-being.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Grouport Comparables

Compare Grouport with similar companies based on industry and business-model similarity.

Grouport comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Circles
83%
Teladoc Health
74%
Monument
71%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Grouport Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 9, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jonathan Spievack

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Grouport Investors

Notable investors and investment history

Grouport investors
InvestorRounds
380 CapSeed
XV Venture CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 14, 2026

    Grew 50% QoQ from 6 to 9 employees.

  • Mar 8, 2024

    Grew 43% QoQ from 7 to 10 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Grouport Filings

Explore SEC and related filing metadata, where available.

Grouport filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Grouport's valuation, stock price, and market status.

Is Grouport a public or private company?

Grouport is a private company.

What is the current stock price of Grouport?

Grouport is a private company, so its shares have no public market price. Caplight tracks Grouport's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Grouport worth (valuation)?

Valuation information for Grouport is not publicly available.

Can I buy Grouport stock?

Grouport shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Grouport's last funding round?

Grouport's most recent funding round was Seed on September 9, 2021.

Who are the main investors in Grouport?

Key investors in Grouport include XV Venture Capital.

Will Grouport IPO soon?

No public IPO plans have been announced for Grouport.

How can I track Grouport secondary market activity?

Caplight tracks bids, offers, and trades in Grouport's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range7
Year Founded2019
Last FundingSep 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?